Stay updated on Pembrolizumab Combo in Chemo-Resistant Tumors Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Combo in Chemo-Resistant Tumors Clinical Trial page.

Latest updates to the Pembrolizumab Combo in Chemo-Resistant Tumors Clinical Trial page
- Check3 days agoChange DetectedThe page footer was updated to reflect a new ClinicalTrials.gov revision version number (from v3.5.2 to v3.5.3). This appears to be a site software/update marker rather than a change to the trial’s information.SummaryDifference0.1%

- Check10 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check38 days agoChange DetectedRecord history shows new Actual dates added (2026-03-13, 2025-12-05, 2026-03-10) and the revision updated to v3.5.0. Older entries (e.g., 2025-11-05, 2025-11-03, 2025-10) were removed.SummaryDifference0.4%

- Check52 days agoChange DetectedAdded Revision: v3.4.3 and removed Revision: v3.4.2.SummaryDifference0.1%

- Check74 days agoChange DetectedRevision updated from v3.4.1 to v3.4.2. No user-facing content changes were made.SummaryDifference0.1%

- Check81 days agoChange DetectedMinor revision history updates: added Revision: v3.4.1 and removed Revision: v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab Combo in Chemo-Resistant Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in Chemo-Resistant Tumors Clinical Trial page.